2006
DOI: 10.17925/ee.2006.00.02.79
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Options in Patients with Microprolactinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2006
2006
2006
2006

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…It seems currently that surgical therapy should be restricted to patients intolerant or resistant to dopamine agonists, and to those with nonfunctional pituitary adenomas or other nonlactothroph adenomas associated with hyperprolactinaemia. 7,14,27…”
Section: S U R G I C a L T H E R A P Ymentioning
confidence: 99%
See 1 more Smart Citation
“…It seems currently that surgical therapy should be restricted to patients intolerant or resistant to dopamine agonists, and to those with nonfunctional pituitary adenomas or other nonlactothroph adenomas associated with hyperprolactinaemia. 7,14,27…”
Section: S U R G I C a L T H E R A P Ymentioning
confidence: 99%
“…Radiotherapy should be offered only to patients for both pharmacotherapy and surgery have failed, and a role for more modern Gamma Knife radiosurgery should be evaluated. 6,7,13,14,27 The future perspectives concern the progress in the medical treatment of prolactinomas resistant to dopamine agonist therapy. There are several potential paths to explore.…”
Section: O N C L U S I O N S a N D P E R S P E C T I V E Smentioning
confidence: 99%